Mirror, Mirror 2024 is your opportunity to explore the impact of policy choices on health and well-being across 10 countries, including the U.S. Read the report here.

Prescription Drugs

Overview Resources

Rows of pills

Controlling Health Care Costs

Key Provisions of Drug Pricing Proposals

publication / Apr 26, 2021

prescription drug prices in the US

Controlling Health Care Costs

Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?

Issue Briefs / Oct 05, 2017

Pharmacist and patient discussing prescription drugs

Controlling Health Care Costs

The Case for Drug-Pricing Reform — The Cost of Inaction

blog / May 26, 2021

Featured

Pills pouring out into a mans hand

Controlling Health Care Costs

Allowing Medicare to Negotiate Drug Prices

Explainer / May 05, 2021

Medicare recipient sorting prescriptions

Controlling Health Care Costs

Inflation Rebate Penalty for Drug Companies

Explainer / Jun 17, 2021

Woman and pharmacist speaking, both wearing masks

Controlling Health Care Costs

Medicare Part D Redesign

Explainer / May 05, 2021

Doris Hölzl, pharmacist, gives FFP2 masks to a customer in a pharmacy in Berlin-Wilmersdorf as part of the free distribution of FFP2 masks to risk groups.

Controlling Health Care Costs

External Reference Pricing: The Drug-Pricing Reform America Needs?

Issue Briefs / May 27, 2021

senior woman on phone looks at pill packets on table

Controlling Health Care Costs

How Federal Drug-Pricing Proposals Could Affect Medicaid

blog / Aug 19, 2021

blue pills in machine manufactured with white gloved hand in background

Controlling Health Care Costs

Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs

blog / Aug 18, 2021

Search content about
Prescription Drugs

Illustration of a bundle of COVID-19 vaccine vials wrapped in U.S. dollars over a world map

Advancing Health Equity

For Global Vaccine Access, Overhaul the Patent System

Podcast / Oct 08, 2021

Chairwoman Carolyn Maloney (D–N.Y.) delivers her opening statement at a hearing

Controlling Health Care Costs

Policymakers’ Attention Turns to Drug Patents in the Debate on Prices

Blog / Oct 07, 2021

Controlling Health Care Costs

The U.S. Can Lower Drug Prices Without Sacrificing Innovation

Blog / Oct 01, 2021

Woman in mask and hat walks outside of CVS pharmacy in parking lot

Controlling Health Care Costs

Medicare Patients Pay More for Drugs Than Older Adults in Other Countries; Congress Has an Opportunity to Move Forward

Blog / Sep 30, 2021

senior woman on phone looks at pill packets on table

Controlling Health Care Costs

How Federal Drug-Pricing Proposals Could Affect Medicaid

Blog / Aug 19, 2021

blue pills in machine manufactured with white gloved hand in background

Controlling Health Care Costs

Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs

Blog / Aug 18, 2021

pharmacist with mask stands behind counter

Controlling Health Care Costs

Competition, Consolidation, and Evolution in the Pharmacy Market

Issue Briefs / Aug 12, 2021

senior man gets prescriptions at pharmacy counter

Controlling Health Care Costs

The Role of Pharmacies in Making Drug Purchasing More Efficient and in Promoting Access to Preventive Care

Issue Briefs / Aug 12, 2021

President Biden speaking at podium in front of American flags and white house seal.

Controlling Health Care Costs

Biden’s Executive Order Promotes Competition to Lower Drug Costs

Blog / Jul 30, 2021

Medicare recipient sorting prescriptions

Controlling Health Care Costs

Inflation Rebate Penalty for Drug Companies

Explainer / Jun 17, 2021

Doris Hölzl, pharmacist, gives FFP2 masks to a customer in a pharmacy in Berlin-Wilmersdorf as part of the free distribution of FFP2 masks to risk groups.

Controlling Health Care Costs

External Reference Pricing: The Drug-Pricing Reform America Needs?

Issue Briefs / May 27, 2021

Pharmacist and patient discussing prescription drugs

Controlling Health Care Costs

The Case for Drug-Pricing Reform — The Cost of Inaction

Blog / May 26, 2021

1 2 3 4 5 6 7 8 9 10 … 14